Unit 3 - Poxviruses Flashcards

1
Q

What is the history of Poxviruses?

A

“Smallpox is the lion king of infectious diseases”

  • Smallpox killed over 500 million people in the 20th century~
  • Compare to 320 million deaths caused by wars, the spanish flu, and AIDS combinded.
  • Smallpox left people scarred by pockmarks and sometimes blind from corneal ulcerations
  • Famous victims and survivors of smallpox
  • Life-mask of composer and pianist Beethoven
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some more things involved in the history of smallpox?

A

First evidence of smallpox

  • Pustular rash on mummified remains of Egyptian Pharaoh Rames V
  • Written descriptions: China and southwestern Asia

Smallpox carried by explorers and traders from the Old world to the New World where the population had no immunity to it

  • Killed an estimated 400,000 Europeans per year during the late 18th century and was responsible for 1/3 of all blindness.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the relationship between smallpox and the new world?

A
  • 15th century: Pizarro and the Incas
  • French and Indian War (1754-1763): Lord Jeffery Amherst provided Native Americans tainted blankets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical features of human poxviruses?

A

Smallpox is caused by two strains of the same virus:

  1. Variola Major: more common, causes a severe form of the disease; overall fatality rate of 30%
  2. Variola Minor: causes a mild form of disease; 1%-2% mortality rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the four types of Variola Major smallpox?

A
  1. Ordinary: accounts for > 89% of cases; 30% mortality rate
  2. Vaccine modified: mild, occured in 2.1% of previously vaccinated person, not lethal
  3. Flat or malignant pox: rare, very severe; lesions do not project above the skin surface; represents 6.7% of cases; 90% mortalilty rate
  4. Hemorrhagic: rare, very severe; hemorrhages develop in skin and mucous membranes; 2.4% of cases; 96% mortality rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are ordinary smallpox?

A

Centrifugal maculopapular rash (less lesions on trunk, more on face and extremities)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are Hemorrhagic Smallpox?

A

The pictures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is variola Minor?

A
  • Less common, mild disease, 1% or less mortality rate
  • Last known person to have natural smallpox of any kind lived in Merka, somalia in 1977.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the Clinical presentations of smallpox?

A

Average incubation period is 12–14 days.

  • Infected individual is not contagious during the incubation period

First symptoms:

  • Fever of 101o to 104oF
  • Splitting headache
  • Severe backache
  • Vomiting (50% of individuals infected)
  • Diarrhea (10% of individuals infected)
  • Delirium and convulsions (7%–15% of individuals infected, usually children)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is involved during the prodromal Phase of Smallpox?

A
  • 2–4 day period
  • May be contagious during this phase
  • Infected individuals too sick to carry on normal daily activities
  • Fever declines, individual feels better (2nd or 3rd day)
  • A macular rash appears around the mouth and on the palate/pharynx
  • Spreads to face, proximal extremities, and finally palms/soles
  • Rash then becomes papular (raised) and vesicular (blistery).
  • Contains large numbers of virus particles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is involved in the progression of smallpox?

A
  • As vesicles rupture, large numbers of virus particles are liberated into the saliva. Person is MOST contagious at this stage!
  • Lesions line the respiratory tract.

Some infected individuals may experience a sore throat.

  • When the vesicles in the mouth start to break, a skin rash appears: first on the face, spreading to the arms, legs, hands and feet within 24 hours.

Rash is described as being centrifugal.
Important in distinguishing smallpox from chickenpox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The smallpox progression continued?

A
  • Skin vesicles mature into pustules by the seventh day.
  • The second week, the rash crusts over.
  • Scabs fall off by days 22–27.
  • In fatal cases, death occurs between days 10 and 16 of the illness.
  • The infected individual remains contagious from the onset of the rash, until all of the scabs come off.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is monkeypox?

A
  • Human infections are rare.
  • Before 1970, recognized as a disease of animals in the rainforests of central and western Africa.
  • Between 1970 and 1986, first human cases reported from Western Africa and Congo basin of Africa as smallpox disappeared.
  • The smallpox vaccine protects individuals from contracting monkeypox.
  • Recommended for those with close contact with individuals or animals confirmed to have monkeypox
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What else in involved in Monkey pox?

A
  • 1996–1997 in 13 villages in Zaire: first human-to-human transmission of monkeypox
  • Lack of smallpox vaccination and an epidemic in animals allowed the virus to jump the species barrier into humans
  • June 2003, U.S. multistate monkeypox outbreak: exotic pet swap meet (prairie dogs)
  • Case fatality rate is 1%–14%
  • Signs and symptoms similar to ordinary or modified smallpox but milder
  • Infected individuals experience a fever, vesicular rash.
  • Monkeypox victims suffer from lymphadenopathy (enlarged lymph nodes) during the early stages of disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Molluscum Contagiosum (MCV)?

A
  • Common poxvirus infection; ~1% of all skin infections
  • Transmitted by direct contact, including sexual contact or more commonly through indirect contact (fomites, e.g., sharing towels from swimming pools).
  • Rapidly transmitted among children at daycares and kindergartens.
  • Becoming a significant opportunistic infection of AIDS patients.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Continue to descrip MCV?

A
  • Incubation period: 2–8 weeks
  • Causes pink, pearl-like lesions (1–5 mm in diameter) on the face (especially eyelids), arms, and legs
  • Lesion has a dimple in the center.
  • Scratching can cause lesions to spread
  • Infection is usually self-limiting in individuals with a competent immune system.
  • Can serve as a marker for severe immune deficiency
  • Secondary bacterial infections are a complication of molluscum contagiosum.
  • The smallpox vaccine does not prevent or protect persons from MCV infection.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is Vaccinia Virus?

A
  • Used to vaccinate individuals against smallpox
  • Also protects against monkeypox infection
  • The exact origin of vaccinia virus is unknown.
  • Genetically most similar to buffalopox
  • Causes a localized skin infection
  • May cause a severe and systemic disease in persons who are immunocompromised or have pre-existing conditions such as eczema or atopic dermatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the Lab diagnosis of poxvirus infections?

A
  • 1949, last natural case of smallpox in the United States
  • Very few physicians in the U.S. have seen an actual case of smallpox.
  • Smallpox is a potential biological weapon.
  • CDC has prepared information and instructions for physicians in case of a smallpox emergency.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the Case Definition of Smallpox?

A
  • Illness with acute onset of fever greater than or equal to 101oF
  • Followed by rash of firm, deep seeded pustules
  • Centrifugal pattern of lesions compared to chickenpox
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the preliminary tests for smallpox?

A
  • Electron microscopy and virus isolation on scrapings of pustules and scabs done by state health laboratories
  • ELISA assays
  • PCR analysis is the only way to accurately distinguish between Variola, monkeypox, and vaccinia infections.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the Cellular Pathogenesis?

A
  • Very little is known about the pathogenesis and virulence of variola virus.
  • The knowledge we have predates modern advances in molecular virology and immunology.
  • Virtually no modern molecular biology has been applied to studying live virus
  • Variola virus is stored safely in two international repositories (Must be worked within a BSL-4 maximum containment facility):
  • CDC, Atlanta, Georgia, U.S.
  • State Research Center of Virology and Biotechnology (Vector), near Novosibirsk, Russia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the naming and structure of poxviruses?

A
  • Variola derived from Latin varius (spotted) or varus (pimple)
  • Poc or pocca—a bag or pouch; describes an exanthematous disease
  • Late 15th century writers used smallpox to distinguish from the great pox, syphilis
23
Q

What are the characteristics of Poxvirus?

A
  • Largest of all animal viruses
  • 270-350 nm on average
  • Enveloped; particles are brick-shaped
  • Clinical specimens have two forms
  • M or mulberry form found in vesicular fluid
  • C or capsule form associated with dried scabs
  • Internally, poxvirus particles have a nucleoid and two lateral bodies surround be an outer membrane (visualized by electron microscopy).
  • Lateral bodies contain essential enzymes
  • dsDNA genomes with closed ends that are 130–230 kilobases in length
  • Ends of the genomes have inverted terminal repeat (ITR) sequences
24
Q

What are the specific structures of a poxvirus?

A

External membrance

Lateral body

palisades

Core Envelope

Core DNA and associated proteins

Lateral Body

25
Q

What is the broad host range of poxviruese?

A
  • Infect many species
  • Most poxviruses named after the animal from which they were origninally isolated (e.g. cowpox, camelpox)
26
Q

What is the Virus File 14-1 Deliberate Use of myxoma poxviruses to control austrailian wild rabbits?

A
  • Rabbits were an invasive species of Australia.
  • The rabbits bred rapidly and caused massive agricultural and environmental damage.
  • Myxoma virus was introduced to control the population.
27
Q

What are the human poxvirus pathogens and their natural hosts?

A

With the exception of variola and MCV …

All poxvirus infections of humans today are zoonoses

28
Q

What is Vaccinia Virus replication?

A
  • Vaccinia is the prototype of poxviruses.
  • Grows in a wide host range of cells in culture (e.g., monkey, rabbit, human, hamster, mouse, etc.)
  • Within 12–24 hours, it can be grown in high titers.

200 bp genome, linear, dsDNA

200 genes

Ends contain ITRs

  • Ends of the genome contain unessential genes
  • More than 40 different poxvirus genomes have been sequenced.
29
Q

What is teh typical poxviurs genome structure?

A
  • 90 essential genes are highly conserved among poxviruses
  • Viral Replication and morphogenesis.
30
Q

What is Vaccinia Virus Replication?

A
  • Two forms of virus particles in cell culture:
  • Extracellular enveloped virion (EEV) contains two membranes (Golgi and plasma membrane)
  • Intracellular mature virion (IMV) contains one membrane (derived from Golgi)
  • IMVs are released upon cell lysis.
  • Each infectious form is thought to enter cells by different mechanisms.
31
Q

What is teh vaccinia virus entry and uncoating?

A

No specific host-cell receptors have been identified.

  • Some studies have shown that the A27L virion protein of vaccinia interacts with cell surface glycosaminoglycans (GAGs).
  • GAGs are ubiquitously expressed on many different cell surfaces.

During uncoating, the outer membrane of EEV is removed and the particle enters the cell, where it loses the second membrane and the viral core passes into the cytoplasm.

32
Q

What is vaccinia virus replicates solely in the cytoplasm of the cell?

A

Unique hallmark of vaccinia/poxviruses:

  • Acquired all functions necessary for genome replication in the cytoplasm
  • All other dsDNA viruses replicate genomes in the nucleus

Gene expression (transcription) is sequential.

Three classes of mRNAs

  • Early (30 min post-infection)
  • Intermediate(100 min post-infection)
  • Late (140 min to 48 hrs posr-infection)
33
Q

What is vaccinia virus replicates solely in the cytoplasm of the cell?

A

Vaccinia virus particle contains transcriptional machinery capable of synthesizing viral mRNAs that are recognized by the cell’s translational machinery.

  • DNA dependent RNA polymerase
  • Transcription factor (VETF)
  • Capping enzymes
  • Methylating enzymes
  • Poly(A) polymerase
  • D10 decapping enzyme involved in mRNA turnover
34
Q

What is the vaccinia gene expression is sequential and temporally regulated?

A
  • Early mRNAs encode enzymes and factors need for transcription of the intermediate class of mRNAs.
  • Intermediate mRNAs encode enzymes and factors required for late gene expression.
  • Late mRNAs expression occurs after DNA replication.

Encodes factors and enzymes packaged into the virion

Structural proteins

35
Q

What is the vaccinia assembly, maturation, and release?

A
  • After the late gene products are synthesized, infectious particles are assembled.
  • Assembly involves interactions with the cytoskeleton (e.g., actin-binding proteins and microtubules).
  • The particles are wrapped with a Golgi-derived membrane and transported to the periphery of the cell.
  • EEV picks up an additional plasma membrane as it is released outside of the cell.
  • EEVs can initiate infection (cell-to-cell spread)
36
Q

What is involved in poxviruses and their immune evasion?

A

Poxviruses produce viroceptors and virokines.

Viroceptors are altered cellular receptors that have lost their transmembrane anchor sequences.

  • Secreted from infected cells
  • Sequester ligands onto the receptor portion of the protein (“cytokine sponges”)

Virokines resemble host cytokines.

  • Secreted like cytokines
37
Q

What other types of poxviruses immune system inhibitors?

A
  • Secreted complement regulatory proteins
  • Secreted proteins that bind to interferons
  • Secreted interleukin-18 binding proteins
  • Secreted tumor necrosis factor homologs (apoptosis inhibitors)
  • Serine protease inhibitors (apoptosis inhibition)
  • Intracellular inhibitors of PKR (interferon pathway)
  • No one specific poxvirus uses all of these collective immune evasion strategies; all seek to target the innate immune response.
38
Q

What is Human genetic and smallpox resistance?

A

1965–1966 study by Vogel and Chakravartii

  • Compared 415 unvaccinated Indian smallpox survivors and victims
  • Persons with Blood Type A were more likely to contract smallpox.
  • Persons with Blood Type A were more likely to develop a severe case.
  • Persons with Blood Type A were more likely to die of it.

2003 study by Galvani and Slatkin

Selective pressure by smallpox resulted in CCR5-32 resistance allele.

Fortuitously, this resistance allele also protects individuals from HIV-1 infection.

39
Q

How is smallpox prevented?

A

Smallpox vaccine history

  • Late 17th century in China

Inhale or plug nose with powdered smallpox scabs

Put underwear of an infected child on a healthy child for several days

  • Variolation practiced by Hindus in India during 16th century.

Intentional inoculation of dried smallpox scabs into the skin of uninfected individuals, causing a mild form of the disease and immunity upon exposure to variola.

40
Q

What is Variolation?

A

Practice spread from central Asia, to east China, west to Africa and the Ottoman Empire

  • 2%–3% of variolated people died from ordinary smallpox infections (compared to 30% mortality)

Lady Mary Wortley Montague, wife of British Ambassador, observed variolation during travels to Istanbul in 1717.

  • Asked Embassy surgeon Charles Maitland to engraft her 4-year- old daughter in 1721
  • Maitland did a study; variolated six prisoners
  • Prisoners survived after exposure to children infected with smallpox.
  • They had a milder form of the disease and developed immunity.
  • Royal Society of London found the practice acceptable and people were variolated in England.
41
Q

Who is Edward Jenner?

A
  • Physician in England, credited with cowpox vaccination
  • Experimented with the folklore that milkmaids who contracted cowpox “did not take the smallpox.”
  • In 1796, Jenner variolated the 8-year-old son of a local farmer with fluid from the cowpox pustules from the hand of a local dairymaid.
  • A few months later, the boy was injected with smallpox and failed to develop the disease.
42
Q

What did Jenna and Vaccination?

A
  • Jenner published his work.
  • Immediate reaction to work was ridicule.
  • Clergy claimed it repulsive and ungodly to inoculate someone with material from a diseased animal.
  • Jenner’s work later accepted and the word vaccination was coined.
  • Vaccinia virus eventually replaced the smallpox virus for vaccination
43
Q

What was the arm to arm passage vaccination?

A
  • Fluid or lymph removed from a vesicle or pustule of a previously vaccinated person was passaged arm-to-arm between humans.
  • Strain was lost occasionally and further strains obtained from cows or horses.
  • Not a safe practice!
  • Vaccine became contaminated with variola major or minor.
  • Way to spread other infectious diseases (e.g., hepatitis B)
  • Arm-to-arm passage banned in 1898
44
Q

What is the U.S. Early Smallpox Vaccine Production?

A
  • These early vaccines were crude and contaminated with cell and bacterial debris.
  • Over time, protocols became standardized.
  • Vaccines were tested for specific pathogens.
  • 1967 WHO recommended seed lot containing Liser or New York City Board of Health strain (NYBOH) grown by Wyeth Laboratories for vaccine production.
45
Q

Why was smallpox a good candidate for eradication?

A
  • Variola has a narrow host range.
  • There are no carriers.
  • There are no animal reservoirs.
  • A highly effective and inexpensive freeze-dried vaccine was available.
  • Surveillance of the disease was easy (centrifugal rash).
  • The WHO created a program to eradicate it.
46
Q

What was the mass-vaccination strategy?

A

1950: hemisphere-effort by Pan American Health Organization to eliminate smallpox

1967: WHO launches plan to eradicate smallpox through mass vaccination.

  • 50 million cases of smallpox worldwide in the early 1950s
  • Each outbreak had to be stopped from spreading via isolation of cases and vaccination of surrounding individuals (“ring vaccination”)
  • Initial problem with inadequate reporting

Over time, goal changed to containment vaccination or surveillance vaccination around newly discovered cases or outbreaks.

  • This strategy evolved after countries like Nigeria and India experienced outbreaks in regions where religious groups refused vaccination.

Use of smallpox recognition cards, containment books, rewards, rumor registers to increase success of surveillance and containment efforts

  • 100 rupees ($12) in 1974
  • 1,000 rupees ($125) in 1975
  • $1,000 in Bangladesh and Somalia in 1978
47
Q

What are vaccine Stockpiles?

A
  • Mass smallpox vaccination was stopped in 1972.
  • U.S. current stockpile consists of
  • New cell culture-derived ACAM2000 vaccine
  • ACAM2000 replacing Dryvax stockpile
  • European Union and WHO vaccines produced from calf lymph
  • These vaccines have not been tested by modern methods for the presence of pathogens.
48
Q

Who is vaccinated today?

What is the Dryvax vaccine?

A

Who is vaccinated today?

  • Laboratory workers who work with poxviruses
  • Healthcare workers (volunteer compliance)
  • Members of the military

Dryvax vaccine

  • Cultured in the skin of calves, freeze-dried
  • Mixed population of vaccinia strains

Bifurcated needle, deltoid of arm

  • Primary inoculation—3 pricks
  • Secondary inoculation—15 pricks
49
Q

What are the Smallpox Vaccine Complications?

A
  • Based on 1960s statistics, 1,000 of every 1 million vaccinees have a serious reaction to the vaccine (0.1%).
  • Serious side effects occur in individuals
  • with skin conditions such as eczema and atopic dermatitis
  • with weakened immune systems
  • with other his risk factors such as high blood pressure, diabetes, and high cholesterol
  • Safer vaccines are needed in case of bioterrorism event that would require mass-vaccination.
50
Q

What are Orthopox Antivirals?

A
  • Smallpox vaccine has been discontinued: no herd immunity to smallpox and monkeypox.
  • No licensed FDA drug to treat smallpox infections.
  • Cidofovir has been used to treat AIDS patients with MCV infections.
  • Target viral genes involved in DNA replication, mRNA synthesis, protein modification, and assembly
51
Q

What is the Variola Destruction Debate?

A
  • All smallpox research must be performed in BSL-4 laboratories.
  • 2005 Intelligence Reform and Terrorism Prevention Act bans synthesis of variola virus from scratch.
  • Does not prohibit researchers from engineering similar poxviruses to contain variola genes.
  • May 2011: Smallpox gets stay of execution
  • 27–7 vote WHO delayed destroying smallpox stockpiles located in the U.S. and Russia
  • 3-5 more years for researchers to study the virus before voting again to keep or destroy stockpiles
52
Q

What is involved in the U.S. Bioterrorism and Biowarfare?

A
  • Use of variola as a biological weapon has a long history.
  • Variola as germ warfare against Native American Indians in French and Indian Wars (1754–1763).
  • Following the Civil War, professional grave robber William Cunningham delivered a corpse of a recently buried smallpox victim to the anatomy dissecting room at the Medical College of Ohio, Cincinnati. Several students were infected.
53
Q

What is Poxviruses as Vaccine Vectors?

A
  • Useful vaccine vector due to their broad host range and ability to generate recombinant viruses that express a variety of foreign antigens
  • Large genome also for insertion of large foreign DNA fragments
  • Recombinant poxviruses to induce mucosal immune responses
  • E.g., rabies,
  • Potential use of attenuated Ankara VV strain, canarypox virus, and fowlpox virus for human vaccination
54
Q

What is the RV144 HIV Vaccine Study?

A
  • 16,402 Thai citizens (60% male, 40%
  • female) enrolled
  • Canarypox vector-based candidate ALVAC-HIV
  • Recombinant gp120 protein based-vaccine
  • Six-year study
  • Reduced the risk of HIV infection by about 31%